Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Fulgent Genetics United States | 507 | 135 |
|
Neuronal Migration Disorders NGS Panel Fulgent Genetics United States | 392 | 83 |
|
Fulgent Genetics United States | 535 | 152 |
|
Blueprint Genetics Finland | 3 | 40 |
|
Polycystic Kidney Disease Panel Blueprint Genetics Finland | 3 | 10 |
|
Blueprint Genetics Finland | 2 | 13 |
|
Blueprint Genetics Finland | 6 | 99 |
|
Fulgent Genetics United States | 23 | 1 |
|
Fulgent Genetics United States | 43 | 1 |
|
Fulgent Genetics United States | 72 | 1 |
|
Fulgent Genetics United States | 45 | 1 |
|
Renal / Urinary Cancer Comprehensive Panel Fulgent Genetics United States | 543 | 27 |
|
Fulgent Genetics United States | 645 | 26 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 1166 | 141 |
|
Dystroglycan-Related Congenital Muscular Dystrophy NGS Panel Fulgent Genetics United States | 67 | 13 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 1103 | 676 |
|
Retinitis Pigmentosa NGS Panel Fulgent Genetics United States | 329 | 124 |
|
Fulgent Genetics United States | 280 | 112 |
|
Fulgent Genetics United States | 110 | 23 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.